The pharmacokinetics and safety of lidocaine in liver cancer patients undergoing hepatic resection.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 829, doi. 10.1007/s00228-023-03498-0
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2023 AND VI 79 AND IP 6
Results: 14
1
2
Could carbamazepine-acetazolamide interaction lead to a severe hepatocellular liver injury? an interaction that needs to be uncovered.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
3
The role of time interval elimination on pain control of preterm infants by sucrose administration.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 841, doi. 10.1007/s00228-023-03496-2
- By:
- Publication type:
- Article
4
Drug information sources in professional work—a questionnaire study on physicians' usage and preferences (the drug information study).
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 767, doi. 10.1007/s00228-023-03494-4
- By:
- Publication type:
- Article
5
Efficacy of Aidi injection combined with chemotherapy, radiotherapy or chemoradiotherapy for unresectable esophageal cancer treatment: A meta-analysis and systematic review of 29 randomized controlled trials based on Asian populations (China).
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 707, doi. 10.1007/s00228-023-03493-5
- By:
- Publication type:
- Article
6
Analysis of clinical characteristics and automatic monitoring of drug-induced arrhythmias in 167,546 inpatients.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 759, doi. 10.1007/s00228-023-03492-6
- By:
- Publication type:
- Article
7
Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 775, doi. 10.1007/s00228-023-03477-5
- By:
- Publication type:
- Article
8
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 859, doi. 10.1007/s00228-023-03490-8
- By:
- Publication type:
- Article
9
A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 815, doi. 10.1007/s00228-023-03489-1
- By:
- Publication type:
- Article
10
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 723, doi. 10.1007/s00228-023-03486-4
- By:
- Publication type:
- Article
11
Association between nocturnal falls and hypnotic drug use in older patients at acute care hospitals.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 753, doi. 10.1007/s00228-023-03485-5
- By:
- Publication type:
- Article
12
Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 789, doi. 10.1007/s00228-023-03491-7
- By:
- Publication type:
- Article
13
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 801, doi. 10.1007/s00228-023-03476-6
- By:
- Publication type:
- Article
14
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 849, doi. 10.1007/s00228-022-03439-3
- By:
- Publication type:
- Article